Showing 1 - 20 results of 23 for search 'A A Kurylev', query time: 0.03s
Refine Results
-
1
What is the role of antineoplastic drug safety in reimbursement decision making? by A. S. Kolbin, A. A. Kurylev
Published 2018-11-01
Article -
2
-
3
-
4
-
5
Overview of mathematical models of breast cancer by Yu. P. Yurkova, A. A. Kurylev, A. S. Kolbin
Published 2019-10-01
Article -
6
-
7
-
8
-
9
-
10
-
11
CYP2D6 genotyping in the daily routine of a psychiatric hospital – pharmacoeconomic evaluation by A. A. Kurylev, B. V. Andreev, A. S. Kolbin, O. V. Limankin
Published 2018-05-01
Article -
12
-
13
Pharmacoeconomic analysis of denosumab in patients with breast cancer and bone metastases by A. S. Kolbin, A. A. Kurylev, M. A. Proskurin, Yu. E. Balykina
Published 2018-05-01
Article -
14
-
15
-
16
-
17
Economic analysis of Lixisenatide in Diabetes Mellitus Type 2 by A. S. Kolbin, A. A. Mosikyan, A. A. Kurylev, Yu. E. Balykina, M. A. Proskurin, W. Zhao
Published 2018-05-01
Article -
18
Modeling microbial drug-resistance: from mathematics to pharmacoeconomics by Yu. M. Gomon, M. A. Arepyeva, Yu. E. Balykina, A. S. Kolbin, A. A. Kurylev, M. A. Proskurin, S. V. Sidorenko
Published 2018-05-01
Article -
19
-
20